ArticleAmerican journal of epidemiology2012
Anti-Müllerian hormone: a potential new tool in epidemiologic studies of female fecundability.
Article in American journal of epidemiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01028365 (Time to Conceive), which is not on this map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Time to Conceive: A Study of Fertility: Biomarkers of Fertility
Who cites it
15 citing papers in PubMed, 30 citations in OpenAlex.
- Serum levels of anti-Müllerian hormone influence pregnancy outcomes associated with gonadotropin-releasing hormone antagonist treatment: a retrospective cohort study.Scientific reports · 2023Article
- Anti-Müllerian Hormone Levels among Female Firefighters.International journal of environmental research and public health · 2022Article
- Urinary Bisphenol A Concentrations and Parameters of Ovarian Reserve among Women from a Fertility Clinic.International journal of environmental research and public health · 2021Article
- Parameters of ovarian reserve in relation to urinary concentrations of parabens.Environmental health : a global access science source · 2020Article
- Anti-Müllerian hormone levels in nurses working night shifts.Archives of environmental & occupational health · 2020Article
- Association between a history of depression and anti-müllerian hormone among late-reproductive aged women: the Harvard study of moods and cycles.Women's midlife health · 2020Article
- Best Practices in Counseling Young Female Cancer Survivors on Reproductive Health.Seminars in reproductive medicine · 2017Review
- Alcohol, cigarette smoking, and ovarian reserve in reproductive-age African-American women.American journal of obstetrics and gynecology · 2016Article
- Anti-mullerian hormone (AMH) is associated with natural menopause in a population-based sample: The CARDIA Women's Study.Maturitas · 2015Article
- Anti-Müllerian hormone and lifestyle, reproductive, and environmental factors among women in rural South Africa.Epidemiology (Cambridge, Mass.) · 2015Article
- Association between serum 25-hydroxyvitamin D and ovarian reserve in premenopausal women.Menopause (New York, N.Y.) · 2015Article
- Active and passive smoking and fecundability in Danish pregnancy planners.Fertility and sterility · 2014Article
- Possible role of autoimmunity in patients with premature ovarian insufficiency.International journal of fertility & sterility · 2014Article
- Oncofertility: Meeting the Fertility Goals of Adolescents and Young Adults With Cancer.Cancer journal (Sudbury, Mass.)Review
- The ageing ovary and uterus: new biological insights.Human reproduction updateReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
The objective of the present commentary is to suggest that epidemiologists explore the use of anti-Müllerian hormone (AMH) as a new measurement tool in fecundability studies. The authors briefly summarize the advantages and limitations of the 3 current approaches to studies of fecundability. All 3 approaches involve the collection of time-to-pregnancy or attempt-time data, and most are limited to participants who plan their pregnancies. AMH is produced by ovarian follicles during their early growth stages and is measured clinically to assess ovarian reserve (the number of remaining oocytes). Unlike time to pregnancy, serum AMH level can be assessed regardless of pregnancy-attempt status. Measurements are not significantly affected by phase of the menstrual cycle, oral contraceptive use, or early pregnancy. The authors suggest that AMH measurement can be a valuable addition to traditionally designed fecundability studies. In addition, this hormone should be investigated as an independent measure of fecundability in studies that focus on exposures hypothesized to target the ovary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.